The RNA 7SK Small Nuclear Pseudogene 275: A Potential Drug Target and Biomarker

Target Name: RN7SKP275

NCBI ID: G106480917

RN7SKP275

Other Name(s): RNA, 7SK small nuclear pseudogene 275 | RN7SK pseudogene 275

The RNA 7SK Small Nuclear Pseudogene 275: A Potential Drug Target and Biomarker

The RNA 7SK small nuclear pseudogene 275 (RNA-7SK-275) is a non-coding RNA molecule that has been identified in various cellular and biological processes. Although its function and significance are not yet fully understood, research has shown that RNA-7SK-275 plays a critical role in various cellular pathways, including cell growth, apoptosis, and DNA replication.

The 7SK gene family is composed of three genes, 7SKD1 (also known as KIAA1), 7SKD2, and 7SKD3. These genes encode for proteins that are involved in the regulation of DNA replication, cell growth, and apoptosis. RNA-7SK-275 is a pseudogene that is derived from the 7SK gene family and is characterized by a unique 275 base pair insertion in the middle of gene.

RNA-7SK-275: A Putative Drug Target

The identification of RNA-7SK-275 as a potential drug target is based on its unique expression patterns and biological functions. Several studies have demonstrated that RNA-7SK-275 is expressed in various tissues and cells, and its levels are highly variable depending on the experimental conditions. Additionally, RNA-7SK-275 has been shown to play a role in the regulation of cellular processes, including cell growth, apoptosis, and DNA replication.

One of the key features that makes RNA-7SK-275 an attractive drug target is its modulation by small molecules, such as drugs, compounds, or mutations. Several studies have shown that RNA-7SK-275 can be modified by various small molecules, leading to changes in its stability, localization, and activity. These modifications can potentially make RNA-7SK-275 more or less responsive to drug intervention, making it an attractive target for drug development.

RNA-7SK-275 as a Biomarker

The expression of RNA-7SK-275 has also been used as a biomarker for various cellular processes, including cell growth, apoptosis, and DNA replication. The levels of RNA-7SK-275 have been shown to be regulated by various factors, including drugs, compounds, or mutations, leading to changes in its stability and activity.

RNA-7SK-275 has been shown to play a critical role in the regulation of DNA replication, which is a key step in the replication of the double-stranded DNA molecule in eukaryotic cells. Studies have shown that RNA-7SK-275 is involved in the regulation of DNA replication by the complex known as the replication factors, including the DF1 and DF2 complex.

Conclusion

In conclusion, RNA-7SK-275 is a pseudogene that has been identified in various cellular and biological processes. Its unique expression patterns and functions make it an attractive target for drug development, as its modulation by small molecules and its role as a biomarker make it a promising candidate for drug discovery. Further research is needed to fully understand the mechanisms of RNA-7SK-275 and its role in various cellular processes.

Protein Name: RN7SK Pseudogene 275

The "RN7SKP275 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RN7SKP275 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets